{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=UMEC", "query": { "intervention": "UMEC" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 28, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=UMEC&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T08:11:58.798Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02164539", "title": "Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "FF", "type": "DRUG" }, { "name": "UMEC", "type": "DRUG" }, { "name": "VI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 338, "start_date": "2014-07-01", "completion_date": "2015-07-18", "has_results": true, "last_update_posted_date": "2017-10-11", "last_synced_at": "2026-09-03T08:11:58.798Z", "location_count": 14, "location_summary": "Newport Beach, California • San Diego, California • Upland, California + 11 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Upland", "state": "California" }, { "city": "Sunset", "state": "Louisiana" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02164539" }, { "nct_id": "NCT02570165", "title": "Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Batefenterol", "type": "DRUG" }, { "name": "Umeclidinium/ Vilanterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 325, "start_date": "2015-11-06", "completion_date": "2016-07-06", "has_results": true, "last_update_posted_date": "2019-07-16", "last_synced_at": "2026-09-03T08:11:58.798Z", "location_count": 9, "location_summary": "Hialeah, Florida • Baltimore, Maryland • St Louis, Missouri + 6 more", "locations": [ { "city": "Hialeah", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Medford", "state": "Oregon" }, { "city": "Anderson", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02570165" }, { "nct_id": "NCT02164513", "title": "A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "fluticasone furoate (FF)", "type": "DRUG" }, { "name": "vilanterol (VI)", "type": "DRUG" }, { "name": "umeclidinium bromide (UMEC)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 10355, "start_date": "2014-06-30", "completion_date": "2017-07-17", "has_results": true, "last_update_posted_date": "2018-10-10", "last_synced_at": "2026-09-03T08:11:58.798Z", "location_count": 269, "location_summary": "Athens, Alabama • Birmingham, Alabama • Florence, Alabama + 226 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Florence", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT02164513" }, { "nct_id": "NCT02799784", "title": "An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "UMEC/VI", "type": "DRUG" }, { "name": "TIO/OLO", "type": "DRUG" }, { "name": "Albuterol/salbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 236, "start_date": "2016-07-14", "completion_date": "2017-04-27", "has_results": true, "last_update_posted_date": "2018-07-02", "last_synced_at": "2026-09-03T08:11:58.798Z", "location_count": 9, "location_summary": "Clearwater, Florida • Orlando, Florida • St Louis, Missouri + 6 more", "locations": [ { "city": "Clearwater", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Medford", "state": "Oregon" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02799784" }, { "nct_id": "NCT02673619", "title": "A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hyperhidrosis" ], "interventions": [ { "name": "Umeclidinium", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stiefel, a GSK Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 58, "start_date": "2016-03-07", "completion_date": "2016-12-08", "has_results": true, "last_update_posted_date": "2018-02-09", "last_synced_at": "2026-09-03T08:11:58.798Z", "location_count": 5, "location_summary": "Omaha, Nebraska • Raleigh, North Carolina • Austin, Texas + 2 more", "locations": [ { "city": "Omaha", "state": "Nebraska" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "Austin", "state": "Texas" }, { "city": "College Station", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02673619" }, { "nct_id": "NCT02152605", "title": "A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "UMEC/VI", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 498, "start_date": "2014-09-01", "completion_date": "2015-03-05", "has_results": true, "last_update_posted_date": "2017-11-09", "last_synced_at": "2026-09-03T08:11:58.798Z", "location_count": 11, "location_summary": "Phoenix, Arizona • Upland, California • Clearwater, Florida + 8 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Upland", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Saint Charles", "state": "Missouri" }, { "city": "Anderson", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02152605" }, { "nct_id": "NCT02924688", "title": "A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FF/UMEC/VI (100/31.25/25) mcg", "type": "DRUG" }, { "name": "FF/UMEC/VI (100/62.5/25) mcg", "type": "DRUG" }, { "name": "FF/UMEC/VI (200/31.25/25) mcg", "type": "DRUG" }, { "name": "FF/UMEC/VI (200/62.5/25) mcg", "type": "DRUG" }, { "name": "FF/VI (100/25) mcg", "type": "DRUG" }, { "name": "FF/VI (200/25) mcg", "type": "DRUG" }, { "name": "Fluticasone/salmeterol (FSC)", "type": "DRUG" }, { "name": "Albuterol/salbutamol", "type": "DRUG" }, { "name": "ELLIPTA DPI", "type": "DEVICE" }, { "name": "DISKUS DPI", "type": "DEVICE" }, { "name": "METERED-DOSE INHALER (MDI)", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2436, "start_date": "2016-10-13", "completion_date": "2019-02-22", "has_results": true, "last_update_posted_date": "2021-03-26", "last_synced_at": "2026-09-03T08:11:58.798Z", "location_count": 99, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 89 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02924688" }, { "nct_id": "NCT03543176", "title": "Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "UMEC/VI", "type": "OTHER" }, { "name": "FLUT/SAL", "type": "OTHER" }, { "name": "CAT", "type": "OTHER" }, { "name": "mMRC", "type": "OTHER" }, { "name": "Ellipta", "type": "DEVICE" }, { "name": "Diskus", "type": "DEVICE" } ], "intervention_types": [ "OTHER", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 789, "start_date": "2018-05-31", "completion_date": "2019-08-21", "has_results": true, "last_update_posted_date": "2020-08-05", "last_synced_at": "2026-09-03T08:11:58.798Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03543176" }, { "nct_id": "NCT02119286", "title": "Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "FF", "type": "DRUG" }, { "name": "VI", "type": "DRUG" }, { "name": "UMEC", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 620, "start_date": "2013-10", "completion_date": "2014-04", "has_results": true, "last_update_posted_date": "2017-03-23", "last_synced_at": "2026-09-03T08:11:58.798Z", "location_count": 14, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Huntington Beach, California + 11 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Huntington Beach", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02119286" }, { "nct_id": "NCT01899742", "title": "The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on Tiotropium", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Umeclidinium/Vilanterol 62.5/25 mcg", "type": "DRUG" }, { "name": "Tiotropium 18 mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 497, "start_date": "2014-09-15", "completion_date": "2015-07-22", "has_results": true, "last_update_posted_date": "2018-01-24", "last_synced_at": "2026-09-03T08:11:58.798Z", "location_count": 3, "location_summary": "Medford, Oregon • Greenville, South Carolina • Spartanburg, South Carolina", "locations": [ { "city": "Medford", "state": "Oregon" }, { "city": "Greenville", "state": "South Carolina" }, { "city": "Spartanburg", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01899742" } ] }